Literature DB >> 30883690

Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study.

Radhika Gangaraju1, Yanjun Chen1, Lindsey Hageman1, Jessica Wu1, Liton Francisco1, Michelle Kung1, Emily Ness1, Mariel Parman1, Daniel J Weisdorf2, Stephen J Forman3, Mukta Arora2, Saro H Armenian3, Smita Bhatia1.   

Abstract

Entities:  

Keywords:  blood or marrow transplantation; subsequent mortality; venous thromboembolism

Mesh：

Year:  2019        PMID： 30883690      PMCID： PMC7768906          DOI： 10.1111/bjh.15866

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.

Authors:  Gualberto Gussoni; Stefania Frasson; Micaela La Regina; Pierpaolo Di Micco; Manuel Monreal
Journal:  Thromb Res       Date:  2012-11-08       Impact factor: 3.944

Review 2.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

3.  Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients.

Authors:  Jorge Labrador; Lucia Lopez-Anglada; Estefania Perez-Lopez; Francisco S Lozano; Lucia Lopez-Corral; Fermin M Sanchez-Guijo; Lourdes Vazquez; Jose Angel Perez Rivera; Francisco Martin-Herrero; Mercedes Sanchez-Barba; Carmen Guerrero; Maria Consuelo del Cañizo; Maria Dolores Caballero; Jesus Fernando San Miguel; Ignacio Alberca; Jose Ramon Gonzalez-Porras
Journal:  Haematologica       Date:  2012-08-16       Impact factor: 9.941

4.  Prognosis of cancers associated with venous thromboembolism.

Authors:  H T Sørensen; L Mellemkjaer; J H Olsen; J A Baron
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 91.245

5.  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Authors:  A A Khorana; C W Francis; E Culakova; N M Kuderer; G H Lyman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

6.  30-year mortality after venous thromboembolism: a population-based cohort study.

Authors:  Kirstine Kobberøe Søgaard; Morten Schmidt; Lars Pedersen; Erzsébet Horváth-Puhó; Henrik Toft Sørensen
Journal:  Circulation       Date:  2014-06-26       Impact factor: 29.690

7.  Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation.

Authors:  Natasha Kekre; Haesook T Kim; Vincent T Ho; Corey Cutler; Philippe Armand; Sarah Nikiforow; Edwin P Alyea; Robert J Soiffer; Joseph H Antin; Jean M Connors; John Koreth
Journal:  Haematologica       Date:  2017-03-24       Impact factor: 9.941
  7 in total
  3 in total

1.  Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study.

Authors:  Radhika Gangaraju; Yanjun Chen; Lindsey Hageman; Jessica Wu; Liton Francisco; Kevin Battles; Michelle Kung; Emily Ness; Mariel Parman; Daniel J Weisdorf; Stephen J Forman; Mukta Arora; Saro H Armenian; Smita Bhatia
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-03       Impact factor: 5.742

Review 2.  Sex-Specific Cardiovascular Risks of Cancer and Its Therapies.

Authors:  Nicholas S Wilcox; Seth J Rotz; McKay Mullen; Evelyn J Song; Betty Ky Hamilton; Javid Moslehi; Saro H Armenian; Joseph C Wu; June-Wha Rhee; Bonnie Ky
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

3.  Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model.

Authors:  Radhika Gangaraju; Yanjun Chen; Lindsey Hageman; Jessica Wu; Liton Francisco; Michelle Kung; Daniel J Weisdorf; Stephen J Forman; Mukta Arora; Saro H Armenian; Smita Bhatia
Journal:  Blood Adv       Date:  2021-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.